Dr. Gillian A. Thomas-Burke

Dr. Gillian A. Thomas-Burke (DR. GILLIAN A. THOMAS-BURKE ) is Doctors Optometrist Physician in Kendall, FL. The NPI Number for Dr. Gillian A. Thomas-Burke is 1821155466.

The current location address for Dr. Gillian A. Thomas-Burke is 12640 N. KENDALL DR. Kendall, FL 33186 and the contact number is 3052737790 and fax number is 3052738018. The mailing address for Dr. Gillian A. Thomas-Burke is 12640 N. KENDALL DR. Kendall, FL 33186- 3052737790 (mailing address contact number - 3052737790).

Doctors of optometry (ODs) are the primary health care professionals for the eye. Optometrists examine, diagnose, treat, and manage diseases, injuries, and disorders of the visual system, the eye, and associated structures as well as identify related systemic conditions affecting the eye. An optometrist has completed pre-professional undergraduate education in a college or university and four years of professional education at a college of optometry, leading to the doctor of optometry (O.D.) degree. Some optometrists complete an optional residency in a specific area of practice. Optometrists are eye health care professionals state-licensed to diagnose and treat diseases and disorders of the eye and visual system.

What is the NPI Number for Dr. Gillian A. Thomas-Burke ?

Answer: The NPI Number for Dr. Gillian A. Thomas-Burke is 1821155466

Where is Dr. Gillian A. Thomas-Burke located?

Answer: Dr. Gillian A. Thomas-Burke is located at 12640 N. KENDALL DR. Kendall, FL 33186.

What is the specialty for Dr. Gillian A. Thomas-Burke ?

Answer: The Specialty of Dr. Gillian A. Thomas-Burke is Doctors Optometrist Physician.

Are there any online reviews for Dr. Gillian A. Thomas-Burke ?

Answer: Yes! Check It Now.

Are there any other health care providers in Kendall, FL?

Answer: Yes, there are given below...

Information on prescription drugs provided to Medicare beneficiaries enrolled in Part D (Prescription Drug Coverage), by physicians and other health care providers, aggregated by provider.

Provider Specialty Type	Optometry
Source of Provider Specialty
Number of Medicare Part D Claims, Including Refills	13
Number of Standardized 30-Day Fills	13
Aggregate Cost Paid for All Claims	2693
Number of Day's Supply for All Claims	265
Number of Medicare Beneficiaries
Number of Claims, Including Refills, for Beneficiaries Age 65+
Including Refills, for Beneficiaries Age 65+
Beneficiaries Age 65+
Number of Day's Supply for All Claims for Beneficaries Age 65+
Number of Medicare Beneficiaries Age 65+
Reason for Suppression of Brnd_Tot_Clms and Brnd_Tot_Drug_Cst	*
Total Claims of Brand-Name Drugs
Reason for Suppression of Gnrc_Tot_Clms and Gnrc_Tot_Drug_Cst	*
Total Claims of Generic Drugs, Including Refills
Aggregate Cost Paid for Generic Drugs
Reason for Suppression of Othr_Tot_Clms and Othr_Tot_Drug_Cst
Total Claims of Other Drugs, Including Refills	0
Aggregate Cost Paid for Other Drugs	0
Reason for Suppression of MAPD_Tot_Clmsand MAPD_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by MAPD Plans	13
Aggregate Cost Paid for Claims Filled by Beneficiaries in MAPD Plans	2693
Reason for Suppression of PDP_Tot_Clms and PDP_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by Standalone PDP Plans	0
Aggregate Cost Paid for Claims Filled by	0
Reason for Suppression of LIS_Tot_Clms and LIS_Drug_Cst	*
Number of Claims for Beneficiaries Covered by Low-Income Subsidy
Aggregate Cost Paid for Claims Covered by Low-Income Subsidy
Reason for Suppression of NonLIS_Tot_Clms and NonLIS_Drug_Cst	*
Number of Claims for Beneficiaries Not Covered by Low-Income Subsidy
by Low-Income Subsidy
Total Claims of Opioid Drugs, Including	0
Aggregate Cost Paid for Opioid Drugs	0
Opioid Claims
Opioid_Tot_Clms divided by the Tot_Clms	0
Total Claims of Long-Acting Opioid Drugs	0
Aggregate Cost Paid for Long-Acting Opioid	0
Number of Day's Supply of All Long-Acting	0
Long-Acting Opioid Claims
Opioid_LA_Tot_Clms divided by the
Total Claims of Antibiotic Drugs, Including	0
Aggregate Cost Paid for Antibiotic Drugs	0
Antibiotic Claims
Reason for Suppression of Antpsyct_GE65_Tot_Clms and Antpsyct_GE65_Tot_Drug_Cst	*
Including Refills, for Beneficiaries Age 65+
Aggregate Cost Paid for AntipsychoticDrugs for Beneficiaries Age 65+
Reason for Suppression of Antpsyct_GE65_Tot_Benes
Number of Medicare Beneficiaries Age 65+Filling Antipsychotic Claims
Average Age of Beneficiaries	73.125
Number of Beneficiaries Age Less Than 65
Number of Beneficiaries Age 65 to 74
Number of Beneficiaries Age 75 to 84
Number of Female Beneficiaries
Number of Male Beneficiaries
Number of Non-Hispanic White
Number of Black or African American
Number of Asian Pacific Islander
Number of Hispanic Beneficiaries
Number of American Indian/Alaskan NativeBeneficiaries
Number of Beneficiaries with Race Not
Only Entitlement
Average Hierarchical Condition Category	1.11875